Global University Venturing

Oxford Immunotec is set to return to private ownership in a $591m acquisition deal.

IP Group portfolio company Hinge Health has pushed its valuation to $3bn following a $300m series D round co-led by Coatue Management and Tiger Global.

UC-backed Congruent Ventures has contributed to a $55m round that will support the recycling robot maker's expansion plans.

Boston Metal is most of the way to a $60m target for its latest round, thanks to a consortium that included returning backer The Engine.

University of Oxford’s autonomous driving software developer Oxbotica has secured $47m in a series B round featuring IP Group as well as several corporates.

The oncolytic virus therapy-based cancer drug developer is based on research at Salk Institute and has raised $77m in its series A round.

Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.

Utec has made its largest initial commitment to date by backing Keio-founded Metcela, a developer of cell therapies for heart disease.

Today’s deal net round ups the smaller investments from across the university innovation ecosystem that have occurred over the holiday period.

Investors have thrown their backing behind a round topping $100m for Stanford-linked production automation robot developer Flexiv.

The intelligent chipmaker, which traces its roots back to University of Bristol, has secured series E funding at a $2.77bn valuation.